VIVEbiotech at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

VIVEbiotech brings 1 presentation to ESGCT 2026 in Hamburg. Its contribution centres on manufacturing lentiviral vectors at scale. The work describes a stable producer cell line platform that removes the transfection step, aiming at higher and more consistent vector quality.

OrganizationESGCT 2026 Attendance
VIVEbiotech
San Sebastián, Spain
◇Silver Sponsor
vivebiotech.com/en
CDMOs & CROsSilver Sponsor
CDMO that develops and GMP-manufactures lentiviral vectors for ex vivo cell therapies such as CAR-T and for in vivo gene therapies.
Poster
Wed Oct 28
1:30pm–3:30pm
EvoLVcell: A Transfection-Free Stable Producer Cell Line Platform for Scalable and High-Quality Lentiviral Vector Manufacturing
Manufacturing

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from VIVEbiotech

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction